Results 161 to 170 of about 62,239 (284)
EHD4 and ASAP2 are critical negative regulators of the claudin‐5‐based endothelial barrier
The FEBS Journal, EarlyView.Cell‐surface CLDN‐5 protein levels can be evaluated using a probe that can bind to the extracellular domains of CLDN‐5. A probe derived from Clostridium perfringens enterotoxin allows us to isolate cells with high CLDN‐5 protein levels from a knockout cell library.
Yosuke Hashimoto +8 more
wiley +1 more source
Journal of Diabetes Investigation, EarlyView.Under physiological conditions, deformable erythrocytes pass smoothly through the capillary network, maintaining retinal capillary perfusion (A). In pathological conditions, reduced erythrocyte deformability causes irregular passage and stagnation within capillaries, resulting in localized blood flow stasis and microvascular congestion, leading to ...
Ye Eun Han +5 more
wiley +1 more source
Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review
Photochemistry and Photobiology, EarlyView.Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima +6 more
wiley +1 more source
Ranibizumab on optic disc perfusion in central retinal vein occlusion. [PDF]
Int J OphthalmolLi X, Hao XF, Xie LK, Luo JH, Zhang MJ.
europepmc +1 more source
Central and Hemicentral Retinal Vein Occlusion
, 2011 Sohan Singh Hayreh +2 more
openalex +2 more sources
Activated protein C resistance in young adults with central retinal vein occlusion. [PDF]
, 1996 Jörgen Larsson +2 more
openalex +1 more source
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma
Veterinary and Comparative Oncology, EarlyView.ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks +5 more
wiley +1 more source
Unilateral Central Retinal Vein Occlusion in a Young Adult With Latent Syphilis. [PDF]
CureusChew LL, Iqbal T, Ibrahim N, Tiong KI.
europepmc +1 more source
Efficacy of panretinal laser in ischemic central retinal vein occlusion: A systematic review
, 2018 Chengfang Li +6 more
openalex +2 more sources